Global Balloon Valvuloplasty Device Market
Medical Equipment

Global Balloon Valvuloplasty Device Market Revenue and Share Analysis Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the balloon valvuloplasty device market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Balloon Valvuloplasty Device Market In The Period 2029-2034?

The market for balloon valvuloplasty devices has experienced substantial growth in recent years. Projections indicate an increase from $2.44 billion in 2024 to $2.57 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.3%. This historical expansion can be attributed to factors such as rising healthcare expenditure, the expansion of healthcare infrastructure, enhanced awareness and diagnostic capabilities, a preference for outpatient settings, the growth of telemedicine improving access, and a strong emphasis on elevating the quality of life for patients.

The balloon valvuloplasty device market size is projected to experience robust expansion over the coming years. This market is anticipated to reach $3.2 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.6%. This anticipated growth within the projection period is linked to several factors, including the rising incidence of heart valve ailments among older demographics globally, the greater embrace of less invasive therapies for heart valve issues, faster approvals and market clearances for novel balloon valvuloplasty devices, and a sustained emphasis on affordable healthcare solutions. Key developments expected during this forecast period encompass improved imaging technologies supporting accurate diagnosis, tailored medicine strategies, heightened investments in research and development, the expansion of regenerative methods in managing cardiovascular diseases, and the incorporation of digital health innovations.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17090&type=smp

What Strategic Drivers Are Accelerating The Balloon Valvuloplasty Device Market Expansion?

The increasing preference for minimally invasive procedures is projected to fuel the expansion of the balloon valvuloplasty device market in the future. These procedures involve medical techniques carried out via small cuts or natural bodily orifices, leading to less trauma and quicker recovery in contrast to conventional operations. The uptake of minimally invasive procedures is growing because they offer shorter recovery periods, a decreased likelihood of complications, and less pain after surgery compared to traditional methods. Within minimally invasive surgical procedures, balloon valvuloplasty devices are utilized to enlarge constricted heart valves, enhance blood circulation, and alleviate symptoms. For example, in January 2024, Intuitive Surgical Inc., a US-based maker of robotic products, disclosed the deployment of 415 da Vinci surgical systems (robotic surgical systems employing a minimally invasive surgical approach) during the fourth quarter of 2023, marking a 12% rise from 2022. Consequently, the growing preference for minimally invasive procedures is propelling the expansion of the balloon valvuloplasty device market.

What Is The Detailed Segment Distribution Of The Balloon Valvuloplasty Device Market?

The balloon valvuloplasty devicemarket covered in this report is segmented –

1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon

2) By Age Group: Pediatric, Adult

3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Standard Balloon: Non-Compliant Balloons, Compliant Balloons

2) By Cutting Balloon: Single-Cutting Balloon, Multi-Cutting Balloon

3) By Scoring Balloon: Single-Score Balloons, Dual-Score Balloons

4) By High-Pressure Balloon: Non-Compliant High-Pressure Balloons, Compliant High-Pressure Balloons

5) By Low-Pressure Balloon: Semi-Compliant Low-Pressure Balloons, Non-Compliant Low-Pressure Balloons

How Are Global Trends Impacting The Development Of The Balloon Valvuloplasty Device Market?

Companies operating in the balloon valvuloplasty device market are focusing on developing advanced products, such as Pacing Guidewires, to secure a competitive advantage. A pacing guidewire is a specialized wire used to provide temporary cardiac pacing during the procedure, ensuring the heart maintains a stable rhythm while the balloon catheter is inserted and inflated to dilate the narrowed valve. For instance, in June 2023, Teleflex Incorporated, a US-based medical device company, obtained clearance from the Food and Drug Administration (FDA) for the Wattson Temporary Pacing Guidewire. This innovative device is specifically designed for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures. The Wattson Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during these structural heart procedures. Its flexible distal pigtail shape, multiple electrodes, and bipolar design are engineered to help reduce the risk of ventricular perforation while providing reliable electrical capture during rapid pacing.

Who Are The Major Stakeholders Operating In The Balloon Valvuloplasty Device Market?

Major companies operating in the balloon valvuloplasty device market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Philips Healthcare, Becton Dickinson Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Biotronik SE & Co. KG, Integer Holdings Corporation, LivaNova PLC, Cordis Corporation, NuMED Inc., Pfm Medical GmbH, Tokai Medical Products Inc, Translumina GmbH, Meril Life Sciences Pvt. Ltd., Toray Medical Company Limited, QT Vascular Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Balloon Valvuloplasty Device Market?

North America was the largest region in the balloon valvuloplasty device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=17090&type=smp

Browse Through More Reports Similar to the Global Balloon Valvuloplasty Device Market 2025, By The Business Research Company

Pta Balloon Catheter Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report

Drug Coated Balloons Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Drug Eluting Balloons Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model